India to Myanmar: Roxithromycin Export Trade Route
India has recorded 24 verified shipments of Roxithromycin exported to Myanmar, representing a combined trade value of $233.2K USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $9.7K USD. The leading Indian exporter is PANGENE BIOTECH LTD , which accounts for 19% of total export value with 4 shipments worth $44.0K USD. On the buying side, LUCKY ASIA INTERNATIONAL CO,, LTD is the largest importer in Myanmar with $44.0K USD in purchases. The top 3 suppliers β PANGENE BIOTECH LTD , MERCURY LABORATORIES LIMITED, THEON PHARMACEUTICALS LIMITED β together control 48% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Myanmar Roxithromycin corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $233.2K USD. The route is dominated by PANGENE BIOTECH LTD , which alone accounts for roughly 19% of all export value, reflecting the consolidated nature of India's roxithromycin manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $9.7K USD β a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with roxithromycin's non-urgent bulk-order profile.
Shipment activity peaks during AprilβJune, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 17.2%, placing it at rank #15 among India's top roxithromycin export destinations globally.
On the import side, key buyers of Indian roxithromycin in Myanmar include LUCKY ASIA INTERNATIONAL CO,, LTD , To The Order, TO THE ORDER OF INDIAN BANK and 13 others. LUCKY ASIA INTERNATIONAL CO,, LTD is the single largest importer with 4 shipments valued at $44.0K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#15
- Annual growth+17.2%
- Demand growth+14.9%
- Regulatory ease82/100
Top 10 Indian Roxithromycin Exporters to Myanmar
Showing top 10 of 14 Indian suppliers exporting Roxithromycin to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANGENE BIOTECH LTD Avg $11.0K per shipment | 4 | $44.0K | 18.9% |
| 2 | MERCURY LABORATORIES LIMITED Avg $37.4K per shipment | 1 | $37.4K | 16.0% |
| 3 | THEON PHARMACEUTICALS LIMITED Avg $15.6K per shipment | 2 | $31.2K | 13.4% |
| 4 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $7.1K per shipment | 3 | $21.2K | 9.1% |
| 5 | ASMOH LABORATORIES LIMITED Avg $17.5K per shipment | 1 | $17.5K | 7.5% |
| 6 | THEON PHARMACEUTICALS LIMITED Avg $15.7K per shipment | 1 | $15.7K | 6.7% |
| 7 | GLOBAL PHARMA HEALTH CARE PVT LTD Avg $15.1K per shipment | 1 | $15.1K | 6.5% |
| 8 | RHYDBURG PHARMACEUTICALS LIMITED Avg $6.3K per shipment | 2 | $12.6K | 5.4% |
| 9 | ZEE LABORATORIES LIMITED Avg $2.9K per shipment | 4 | $11.5K | 4.9% |
| 10 | GLOBAL PHARMA HEALTH CARE PRIVATE LIMITED Avg $11.4K per shipment | 1 | $11.4K | 4.9% |
This table shows the top 10 of 14 Indian companies exporting roxithromycin to Myanmar, ranked by total trade value. The listed exporters are: PANGENE BIOTECH LTD , MERCURY LABORATORIES LIMITED, THEON PHARMACEUTICALS LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED, ASMOH LABORATORIES LIMITED , THEON PHARMACEUTICALS LIMITED, GLOBAL PHARMA HEALTH CARE PVT LTD, RHYDBURG PHARMACEUTICALS LIMITED, ZEE LABORATORIES LIMITED, GLOBAL PHARMA HEALTH CARE PRIVATE LIMITED. PANGENE BIOTECH LTD is the dominant supplier with 4 shipments worth $44.0K USD, giving it a 19% market share. The top 3 suppliers together account for 48% of the total trade value on this route.
Showing top 10 of 14 total Indian exporters on the India to Myanmar Roxithromycin export route.
Top 10 Roxithromycin Importers in Myanmar
Showing top 10 of 16 known buyers in Myanmar receiving Roxithromycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian roxithromycin in Myanmar include LUCKY ASIA INTERNATIONAL CO,, LTD , To The Order, TO THE ORDER OF INDIAN BANK , NS BLUE SKY PTE LIMITED , BIO SYSTEM BIO SYS CO LIMITED, among 16 total buyers. The largest importer is LUCKY ASIA INTERNATIONAL CO,, LTD , accounting for $44.0K USD across 4 shipments β representing 19% of all roxithromycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUCKY ASIA INTERNATIONAL CO,, LTD | 4 | $44.0K | 18.9% |
| 2 | To The Order | 2 | $42.5K | 18.2% |
| 3 | TO THE ORDER OF INDIAN BANK | 2 | $31.2K | 13.4% |
| 4 | NS BLUE SKY PTE LIMITED | 1 | $17.5K | 7.5% |
| 5 | BIO SYSTEM BIO SYS CO LIMITED | 1 | $15.7K | 6.7% |
| 6 | NOTIFY PARTY | 1 | $15.1K | 6.5% |
| 7 | LUCKY ASIA INTERNATIONAL CO LTD | 1 | $12.2K | 5.2% |
| 8 | NA | 1 | $11.4K | 4.9% |
| 9 | LUCKY ASIA INTERNATIONAL CO., LTD | 2 | $9.1K | 3.9% |
| 10 | PHARMACEUTICAL PRODUCT LTD | 3 | $8.2K | 3.5% |
Showing top 10 of 16 Roxithromycin importers in Myanmar on this route.
Top 10 Roxithromycin Formulations Imported by Myanmar
Showing top 10 of 19 product formulations shipped on the India to Myanmar Roxithromycin route, ranked by trade value
Myanmar imports a wide range of roxithromycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation β ROXYLAB ORAL SUSP (ROXITHROMYCIN BP 50MG β accounts for $44.0K USD across 4 shipments. There are 19 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ROXYLAB ORAL SUSP (ROXITHROMYCIN BP 50MG | 4 | $44.0K | 18.9% |
| 2 | R MYCIN 150 ROXITHROMYCIN TABLETS 150 MG | 1 | $37.4K | 16.0% |
| 3 | ROXIMIN (ROXITHROMYCIN TABLETS 150MG)B.N | 2 | $31.2K | 13.4% |
| 4 | ROXIMO-150 ROXITHROMYCIN BP 150 MG TABLE | 1 | $17.5K | 7.5% |
| 5 | ROXIMIN Roxithromycin Tablets 150mg | 1 | $15.7K | 6.7% |
| 6 | HARMLESS MEDICINES- ROX-150 ROXITHROMYCIN 150 MG TABLET UNIT-10X10'S QTY-6601. | 1 | $15.1K | 6.5% |
| 7 | ZYROX 150 MG TAB ROXITHROMYCIN TAB 150 MG PACK 10X20 PHARMACEUTICAL FORMULATIONS | 1 | $12.2K | 5.2% |
| 8 | HARMLESS MEDICINES-ROX 150 ROXITHROMYCIN | 1 | $11.4K | 4.9% |
| 9 | ZYROX 150MG TAB(ROXITHROMYCIN TAB 150 MG)(PACK:10X20)(PHARMACEUTICAL FORMULATIONS)NOS | 1 | $9.1K | 3.9% |
| 10 | REROX TABLET 10 ALU PVC BLISTER X 10 TABS X 1 ROXITHROMYCIN TABLETS 150 MGBT#TE2312446MFG#DEC-2023EXP#NOV-2026NOS | 1 | $7.5K | 3.2% |
Showing top 10 of 19 Roxithromycin formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 4 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's roxithromycin exports to Myanmar are driven primarily by a handful of large-scale manufacturers. PANGENE BIOTECH LTD with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market β buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers β PANGENE BIOTECH LTD , MERCURY LABORATORIES LIMITED, THEON PHARMACEUTICALS LIMITED β together account for 48% of total trade value on this route. The average shipment value of $9.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as r mycin 150 roxithromycin tablets 150 mg and roximin (roxithromycin tablets 150mg)b.n , suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LUCKY ASIA INTERNATIONAL CO,, LTD is the largest importer with 4 shipments worth $44.0K USD β representing 19% of all roxithromycin imports from India on this route. A total of 16 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $233.2K
- Avg. Shipment
- $9.7K
- Suppliers
- 14
- Buyers
- 16
- Transit (Sea)
- ~21 days
- Annual Growth
- +17.2%
Related Analysis
Other Roxithromycin Routes
Unlock the Full India to Myanmar Roxithromycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 24 shipments on this route.
Frequently Asked Questions β India to Myanmar Roxithromycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Roxithromycin to Myanmar?
The leading Indian exporters of Roxithromycin to Myanmar are PANGENE BIOTECH LTD , MERCURY LABORATORIES LIMITED, THEON PHARMACEUTICALS LIMITED . PANGENE BIOTECH LTD holds the largest market share at approximately 19% of total trade value on this route.
Q What is the total value of Roxithromycin exports from India to Myanmar?
India exports Roxithromycin to Myanmar worth approximately $233.2K USD across 24 recorded shipments. The average value per shipment is $9.7K USD.
Q Which ports does India use to ship Roxithromycin to Myanmar?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 4 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Myanmar for Roxithromycin?
The average transit time for Roxithromycin shipments from India to Myanmar is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during AprilβJune.
Q Is the India to Myanmar Roxithromycin trade route growing?
Yes β this trade corridor has seen an annual growth rate of approximately 17.2% with demand growth tracking at 14.9%. The route is ranked #15 among India's top Roxithromycin export destinations globally.
Q How many suppliers are active on the India to Myanmar Roxithromycin route?
There are currently 14 active Indian suppliers exporting Roxithromycin to Myanmar. The market is moderately concentrated with PANGENE BIOTECH LTD accounting for 19% of total shipment value.
Q Who are the main importers of Roxithromycin from India in Myanmar?
The leading importers of Indian Roxithromycin in Myanmar include LUCKY ASIA INTERNATIONAL CO,, LTD , To The Order, TO THE ORDER OF INDIAN BANK , NS BLUE SKY PTE LIMITED , BIO SYSTEM BIO SYS CO LIMITED. LUCKY ASIA INTERNATIONAL CO,, LTD is the largest buyer with 4 shipments worth $44.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India β Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce β Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Roxithromycin.
- 2.Supplier/Buyer Matching: 14 Indian exporters and 16 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 24 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
24 Verified Shipments
14 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists